nonprofit logo

Phare Bio Inc

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 851085804 ✦ Boston, MA ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Phare Bio Inc?

Phare Bio Inc is a Boston-based nonprofit organization, located at 303 Congress Street 2nd Floor, specializing in addressing the looming crisis of antibiotic resistance. Utilizing cutting-edge AI/deep learning technology, Phare Bio aims to rapidly discover and develop novel classes of antibiotics, targeting the deadliest pathogens. With a small workforce of just two individuals, the organization's mission is to ensure these life-saving therapies reach those in greatest need, overcoming economic challenges in the antibiotic market. By partnering with Professor Jim Collins' lab at MIT, Phare Bio leverages advanced technology to develop critically needed antibiotics, contributing to the global fight against antibiotic resistance.


Official website here: www.pharebio.org

What are the reviews and ratings of this charity?

Charity Navigator Rating: 95% (Four-Star out of Four Star Rating)

Phare Bio Inc has achieved a commendable Four-Star rating from Charity Navigator, indicating a high level of accountability and financial health. The organization scored 95% overall, with its rating being based entirely on its Accountability & Finance metrics. This strong rating reflects the charity's transparent practices, as evidenced by their independent board members and comprehensive financial oversight.

The organization demonstrates significant strength in various areas, including a fully independent board and robust financial policies. It has maintained a perfect score in areas such as conflict of interest policies, whistleblower protections, and financial statement oversight. Additionally, the charity's program expense ratio indicates that a substantial portion of its budget is allocated directly to its programs, which is a positive sign for potential donors.

However, while the charity exhibits strong fiscal responsibility, the program expense ratio of 65.92% suggests that there may be room for improvement in optimizing funds for direct programmatic activities. Overall, Phare Bio Inc's strong financial practices and accountability measures position it well for continued support and contributions from the community.


This AI summary has been generated from information found on Charity Navigator.

Is Phare Bio Inc legitimate?

Phare Bio Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Phare Bio Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $650,167
Professional Fundraising Fees: $0
Other Salaries and Wages: $0

For more financial information, click here


Official website here: www.pharebio.org

What is the mission statement of Phare Bio Inc?

Phare Bio Inc's mission is centered around combating the looming crisis of antibiotic resistance. Utilizing advanced AI and deep learning approaches, the company aims to expeditiously discover and develop novel classes of antibiotics against the deadliest pathogens. The goal is to ensure these life-saving therapies reach those in greatest need. Phare Bio has several promising early-stage pipeline projects and is conducting extensive in vitro and in vivo drug development studies. The antibiotic candidates are discovered through a unique AI/deep learning platform developed in collaboration with Professor Jim Collins' lab at MIT and optimized for future clinical application at Phare Bio. With this cutting-edge platform and a non-profit business model, Phare Bio is uniquely addressing economic challenges in the antibiotic market and developing novel classes of antibiotics.


Official website here: www.pharebio.org

Who is the CEO of Phare Bio Inc?

Akhila Kosaraju is the Ceo & President of Phare Bio Inc. The CEO's salary of Phare Bio Inc is $395,154 and their total compensation is $417,333.


Official website here: www.pharebio.org

What is the revenue of Phare Bio Inc?

Phare Bio Inc's revenue in 2022 was $1,558,823.


Official website here: www.pharebio.org

Who are the executives of Phare Bio Inc and what are their salaries?

The average compensation at Phare Bio Inc during 2022 was $325,084. There are 2 employees and 6 volunteers at Phare Bio Inc.


Here are 7 key members and their salaries (Phare Bio Inc's CEO's salary is $395,154 and their total compensation is $417,333):


Akhila Kosaraju (Ceo & President)
  • Compensation: $395,154
  • Related: $0
  • Other: $22,179
William Foster (Chair & Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Steve Ellis (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
James Collins (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jose-Carlos Guttierez-Ramos (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Robert Plenge (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Susan Urahn (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0


Official website here: www.pharebio.org

Where can I find the form 990 for Phare Bio Inc?

Phare Bio Inc's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.pharebio.org

Learn more at the official website: www.pharebio.org

Mission Statement of Phare Bio Inc

Phare Bio, a pioneering organization, is dedicated to combating the looming crisis of antibiotic resistance through innovative approaches. Utilizing advanced AI and deep learning techniques, Phare Bio's mission is to rapidly discover and develop new classes of antibiotics targeting the deadliest pathogens. Their objective is to ensure these life-saving therapies reach those in greatest need.

Professor Jim Collins' lab at MIT, Phare Bio's AI discovery partner and co-founder, has developed a novel platform for this purpose. Phare Bio leverages this technology to identify potential antibiotics and optimizes them for future clinical application. With a nonprofit business model, Phare Bio is uniquely addressing economic challenges in the antibiotic market, thereby contributing significantly to the development of novel antibiotics to combat antibiotic resistance.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




July, 2024

Phare Bio Inc's impact lies in its cutting-edge approach to combatting antimicrobial resistance. By utilizing AI and deep learning technologies, Phare Bio is at the forefront of developing critically needed antibiotics to address a looming crisis in antibiotic resistance. The organization's mission is to rapidly discover and develop new classes of antibiotics against the deadliest pathogens, with the ultimate goal of ensuring that these therapies reach the patients in greatest need. Through its innovative research and development process, Phare Bio is uniquely positioned to make a significant contribution to the field of medical research and potentially save countless lives affected by antibiotic-resistant infections.




This information is meant to be a general summary of Phare Bio Inc. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$1,558,823 (2022)
Expenses
$1,178,664 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Gross Receipts: $1,558,823

Assets and Liabilities:

  • Total Assets: $1,009,435
  • Total Liabilities: $25,465
  • Net Assets: $983,970

Want to help this charity, for free? You can click here to learn more about Give Freely

Organization Details

Founding Year

2020

Principal Officer

Akhila Kosaraju

Main Address

303 CONGRESS STREET 2ND FLOOR, BOSTON, MA, 02210

NTEE Category

Code: H99 - Medical research

If you are a representative of Phare Bio Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.